|
|
|
Volumn 28, Issue 4, 2001, Pages 639-642
|
|
Issues surrounding adjuvant chemotherapy for breast cancer during pregnancy.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
ADULT;
ARTICLE;
BREAST FEEDING;
BREAST TUMOR;
CASE REPORT;
CONGENITAL MALFORMATION;
DECISION MAKING;
FEMALE;
GENETIC COUNSELING;
HUMAN;
INFORMED CONSENT;
LIVING WILL;
OBJECT RELATION;
PREGNANCY;
PREGNANCY COMPLICATION;
RISK ASSESSMENT;
SAFETY;
ABNORMALITIES, DRUG-INDUCED;
ADULT;
ADVANCE DIRECTIVES;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST FEEDING;
BREAST NEOPLASMS;
CONSUMER PRODUCT SAFETY;
CYCLOPHOSPHAMIDE;
DECISION MAKING;
DOXORUBICIN;
FEMALE;
GENETIC COUNSELING;
HUMANS;
INFORMED CONSENT;
OBJECT ATTACHMENT;
PREGNANCY;
PREGNANCY COMPLICATIONS, NEOPLASTIC;
RISK ASSESSMENT;
|
|
EID: 0035348796
PISSN: 0190535X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (9)
|
|
References (0)
|
